Back
Cadrenal Therapeutics Stock Price Chart
Sponsored
CVKD
Sponsored
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
80
CVKD
Cadrenal Therapeutics
Last Price:
12.58
Seasonality Move:
25.47%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVKD is experiencing selling pressure, which indicates risk of future bearish movement.
Cadrenal Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.18 | Sell |
20-day SMA: | 14.29 | Sell |
50-day SMA: | 14.65 | Sell |
200-day SMA: | 9.52 | Buy |
8-day EMA: | 13.06 | Sell |
20-day EMA: | 13.95 | Sell |
50-day EMA: | 13.84 | Sell |
200-day EMA: | 11.65 | Buy |
Cadrenal Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.68 | Sell |
Relative Strength Index (14 RSI): | 41.1 | Sell |
Chaikin Money Flow: | -111709 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.17 - 16.53) | Sell |
Bollinger Bands (100): | (7.81 - 15.33) | Buy |
Cadrenal Therapeutics Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cadrenal Therapeutics Stock
Is Cadrenal Therapeutics Stock a Buy?
- Cadrenal Therapeutics share price is 12.55 while CVKD 8-day simple moving average is 13.18, which is a Sell signal.
- The stock price of CVKD is 12.55 while Cadrenal Therapeutics 20-day SMA is 14.29, which makes it a Sell.
- Cadrenal Therapeutics 50-day simple moving average is 14.65 while CVKD share price is 12.55, making it a Sell technically.
- CVKD stock price is 12.55 and Cadrenal Therapeutics 200-day simple moving average is 9.52, creating a Buy signal.
CVKD Technical Analysis vs Fundamental Analysis
Buy
80
Cadrenal Therapeutics (CVKD)
is a Buy
Is Cadrenal Therapeutics a Buy or a Sell?
-
Cadrenal Therapeutics stock is rated a Buy
The current Cadrenal Therapeutics [CVKD] share price is $12.55. The Score for CVKD is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
Cadrenal Therapeutics Stock Info
Market Cap:
20.82M
Price in USD:
12.55
Share Volume:
132.66K
Cadrenal Therapeutics 52-Week Range
52-Week High:
32.55
52-Week Low:
5.40
Buy
80
Cadrenal Therapeutics (CVKD)
is a Buy
Cadrenal Therapeutics Share Price Forecast
-
What is the Cadrenal Therapeutics stock price today?
The Cadrenal Therapeutics stock price is 12.55 USD today. -
Will CVKD stock go up or go down?
Cadrenal Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cadrenal Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cadrenal Therapeutics is not overvalued.
Is Cadrenal Therapeutics Stock a Buy?
- Cadrenal Therapeutics share price is 12.55 while CVKD 8-day exponential moving average is 13.06, which is a Sell signal.
- The stock price of CVKD is 12.55 while Cadrenal Therapeutics 20-day EMA is 13.95, which makes it a Sell.
- Cadrenal Therapeutics 50-day exponential moving average is 13.84 while CVKD share price is 12.55, making it a Sell technically.
- CVKD stock price is 12.55 and Cadrenal Therapeutics 200-day simple moving average is 11.65, creating a Buy signal.
Fundamental Analysis of Cadrenal Therapeutics
Is Cadrenal Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.81 per share, and an increase next year of $3.53 per share.
Technical Analysis of Cadrenal Therapeutics
Should I short Cadrenal Therapeutics stock?
- CVKD Moving Average Covergence Divergence (MACD) indicator is -0.68, suggesting Cadrenal Therapeutics is a Sell
- Cadrenal Therapeutics Relative Strength Index (RSI) is 41.1, which suggest Cadrenal Therapeutics is oversold
- The Bollinger Bands (25) for Cadrenal Therapeutics is (13.17 - 16.53), which suggest Cadrenal Therapeutics is a Buy
- The Bollinger Bands (100) for Cadrenal Therapeutics is (7.81 - 15.33), which suggest Cadrenal Therapeutics is a Buy
* Cadrenal Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.